| Drug Name: | Ouabain (630-60-4) |
|---|---|
| PubChem ID: | 439501 |
| SMILES: | C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@H]2C[C@H]([C@@]3([C@@H]4[C@@H](CC[C@@]3(C2)O)[C@]5(CC[C@@H]([C@]5(C[C@H]4O)C)C6=CC(=O)OC6)O)CO)O)O)O)O |
| InchiKey: | LPMXVESGRSUGHW-HBYQJFLCSA-N |
| Therapeutic Category: | Cardiotonic Agents, Cardiovascular Agents, Enzyme Inhibitors, Protective Agents |
| Molecular Weight (dalton) | : | 584.659 |
| LogP | : | -1.515 |
| Ring Count | : | 0 |
| Hydrogen Bond Acceptor Count | : | 12 |
| Hydrogen Bond Donor Count | : | 8 |
| Total Polar Surface Area | : | 206.6 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category